Aurobindo Pharma, Glenmark recall products in US

Aurobindo Pharma and Glenmark Pharmaceuticals have both initiated voluntary recalls of certain products due to quality concerns. Aurobindo’s recall involves specific lots of tablets that did not meet the company’s stringent quality standards. Similarly, Glenmark is recalling a batch of its products following concerns about their safety and efficacy. The recalls have been initiated to protect consumer health and maintain the companies’ commitment to quality. This move highlights the growing emphasis on quality control within the pharmaceutical industry, ensuring that products released to the market meet safety and regulatory standards.